KalVista Pharmaceuticals Aktie
14,20
EUR
+0,80
EUR
+5,97
%
16,62
USD
+1,03
USD
+6,61
%
Werbung
KalVista Pharmaceuticals Aktie Analyse
| 20.03.19 | KalVista Pharmaceuticals Buy | Needham & Company, LLC | |
| 21.09.18 | KalVista Pharmaceuticals Overweight | Cantor Fitzgerald | |
| 31.08.17 | KalVista Pharmaceuticals Buy | BTIG Research |
Werbung
Werbung